back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-12-12 13:06 Tx date 2024-05-30 |
$QPT
Quest PharmaTech Inc. |
Glass, Bradley
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Hepalink USA Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
25,000,000 | ||
| Filed 2025-10-21 12:39 Tx date 2025-07-21 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$28,000
+700,000 vol $0.04 each |
700,000 | |
| Filed 2025-10-21 12:38 Tx date 2025-07-21 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
$-40,000
-1,000,000 vol $0.04 each |
0 | |
| Filed 2025-10-21 12:37 Tx date 2025-07-21 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
$12,000
+300,000 vol $0.04 each |
2,500,000 | |
| Filed 2025-07-23 09:54 Tx date 2025-07-21 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
$12,000
+300,000 vol $0.04 each |
||
| Filed 2025-07-23 09:52 Tx date 2025-07-21 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
99 - Correction of information
|
$28,000
+700,000 vol $0.04 each |
||
| Filed 2025-07-23 09:46 Tx date 2025-07-21 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
99 - Correction of information
|
$-40,000
-1,000,000 vol $0.04 each |
||
| Filed 2025-09-05 12:51 Tx date 2024-10-09 |
$QPT
Quest PharmaTech Inc. |
Shon, Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,000
+100,000 vol $0.05 each |
600,000 | |
| Filed 2025-08-29 12:27 Tx date 2025-08-26 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,000
+100,000 vol $0.05 each |
2,250,000 | |
| Filed 2025-08-29 12:24 Tx date 2025-08-26 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+1,500,000 vol $0.05 each |
8,550,000 | |
| Filed 2025-08-29 12:20 Tx date 2025-08-26 |
$QPT
Quest PharmaTech Inc. |
Glass, Bradley
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,000
+100,000 vol $0.05 each |
200,000 | |
| Filed 2025-08-29 12:15 Tx date 2025-08-26 |
$QPT
Quest PharmaTech Inc. |
Lievonen, John Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,000
+100,000 vol $0.05 each |
1,250,000 | |
| Filed 2025-08-29 12:07 Tx date 2025-08-26 |
$QPT
Quest PharmaTech Inc. |
Shon, Jeffrey
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,000
+100,000 vol $0.05 each |
600,000 | |
| Filed 2025-07-23 09:54 Tx date 2025-07-21 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
$12,000
+300,000 vol $0.04 each |
2,500,000 | |
| Filed 2025-07-23 09:52 Tx date 2025-07-21 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
99 - Correction of information
|
$28,000
+700,000 vol $0.04 each |
700,000 | |
| Filed 2025-07-23 09:48 Tx date 2004-06-17 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-07-23 09:46 Tx date 2025-07-21 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
99 - Correction of information
|
$-40,000
-1,000,000 vol $0.04 each |
0 | |
| Filed 2024-11-08 12:48 Tx date 2024-11-07 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-25,000
-250,000 vol $0.10 each |
2,150,000 | |
| Filed 2024-11-08 12:28 Tx date 2024-11-07 |
$QPT
Quest PharmaTech Inc. |
Madiyalakan, Ragupathy
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-100,000
-1,000,000 vol $0.10 each |
7,050,000 | |
| Filed 2024-10-14 12:43 Tx date 2024-10-09 |
$QPT
Quest PharmaTech Inc. |
Glass, Bradley
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,000
+100,000 vol $0.05 each |
100,000 |